Quality of Life and Lung Function on Post Covid-19 Patient
Covid-19
Effect of Breathing Exercise on Chest Expansion, Quality of Life and Lung Function on Post Covid-19 Patient: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Gaining a greater understanding of how the breathing exercise combined with aerobic and strengthening exercises will affects lung function and quality of life in post covid-19 persons
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable covid19
Started Dec 2021
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2021
CompletedFirst Submitted
Initial submission to the registry
December 25, 2021
CompletedFirst Posted
Study publicly available on registry
December 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedApril 4, 2023
April 1, 2023
1.2 years
December 25, 2021
April 2, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Health-related quality of life, Medical Outcomes Study short-form (SF-36)
assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.
at baseline
Health-related quality of life, Medical Outcomes Study short-form (SF-36)
assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.
after 6 weeks
Respiratory function measurement
assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).
at baseline
Respiratory function measurement
assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).
after 6 weeks
Secondary Outcomes (4)
Chest expansion measurement
at baseline
Chest expansion measurement
after 6 weeks
Exercise endurance measurement
at baseline
Exercise endurance measurement
after 6 weeks
Study Arms (2)
study group
EXPERIMENTALWill receive diaphragmatic breathing with pursed lips as (breathing exercise), They will instruct to perform 3 different conditions will be registered: (1) 6 min of quiet breathing (3 sets of 2 min each), defined as spontaneous breathing pattern; (2) 6 min of diaphragmatic breathing (3 sets of 2 min each); and (3) 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each). For aerobic exercises: Will include the following exercises: walking, cycling, running and intermittent running. The exercises will perform for 18-60 minutes for 1-2 sets per week. For resistance exercises: Will include the following 8 exercises: shoulder press, biceps curl, triceps curl, bench press, leg squats, leg press, leg curl and toe raise. The exercises will perform for 60 minutes for 2-3 sets per week.
control group
NO INTERVENTIONnot receiving any exercises
Interventions
6 min of quiet breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each).
Eligibility Criteria
You may qualify if:
- Female. Age from 20 to 30 years old. - Body mass index (BMI) 19 to 24 kg/m2.- Non-smoker- Recovered from COVID-19 over the past 12 months. - They are experiencing mild to moderate symptoms without any complications. -
- Able to use online communication programs.
You may not qualify if:
- \- Anyone who does regular physical exercise.
- history of acute illness, asthma, pulmonary fibrosis, hypertension, diabetes disease.
- hypoxemia in rest.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of medical rehabilitation
Buraidah, Al-Qassim Region, 2100, Saudi Arabia
Related Publications (3)
Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020 May;39:101166. doi: 10.1016/j.ctcp.2020.101166. Epub 2020 Apr 1.
PMID: 32379637RESULTMendes LP, Moraes KS, Hoffman M, Vieira DS, Ribeiro-Samora GA, Lage SM, Britto RR, Parreira VF. Effects of Diaphragmatic Breathing With and Without Pursed-Lips Breathing in Subjects With COPD. Respir Care. 2019 Feb;64(2):136-144. doi: 10.4187/respcare.06319. Epub 2018 Aug 28.
PMID: 30154127RESULTUbolnuar N, Tantisuwat A, Thaveeratitham P, Lertmaharit S, Kruapanich C, Mathiyakom W. Effects of Breathing Exercises in Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. Ann Rehabil Med. 2019 Aug;43(4):509-523. doi: 10.5535/arm.2019.43.4.509. Epub 2019 Aug 31.
PMID: 31499605RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sahar Mahmoud, PhD
Qassim University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Assistant Professor of physical therapy, College of Medical Rehabilitation, Qassim University, Saudi Arabia, Qassim, Buraidah. Consultant Physical Therapist
Study Record Dates
First Submitted
December 25, 2021
First Posted
December 29, 2021
Study Start
December 20, 2021
Primary Completion
March 20, 2023
Study Completion
March 30, 2023
Last Updated
April 4, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 6 months after publication
- Access Criteria
- relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.
The data sets generated during and/or analyzed during the current study is available from the corresponding author on reasonable request.